-

SMPP Enters into Teaming Agreement with KNDS for KATANA®
SMPP, one of India’s leading defence and aerospace companies, has entered into a teaming agreement through its subsidiary SMPP Ammunition with KNDS for the KATANA® range of precision-guided artillery ammunition. The KATANA® is a 155mm precision-guided munition designed to deliver high accuracy and extended range, addressing critical operational needs of modern artillery systems. The agreement…
-

Wear the Speed, Live the Convenience: Tappy Technologies Powers the Launch of High Performance Payment Bands in Collaboration with First Abu Dhabi Bank and Mastercard
Mumbai, Maharashtra, India Tappy Technologies, the global leader in wearable payment solutions, is proud to announce that its secure tokenization technology is driving the launch of next-generation contactless payment bands by First Abu Dhabi Bank (FAB) in partnership with Mastercard. Inspired by the adrenaline and precision of motor racing, these bands give consumers a unique…
-

Balu Forge Industries Ltd Secures Major Order for 152mm Artillery Shells; Accelerates Forward Integration in Defence Sector
Balu Forge Industries Ltd (BSE: 531112 | NSE: BALUFORGE), a leading precision engineering and manufacturing company, is pleased to announce the receipt of a significant order in the large-calibre ammunition segment. The company has secured an initial contract to supply 30,000 units of 152 mm artillery shells to a major Indian energetics player. This partnership…
-

Brand Loyalty Reimagined: How Encalm Transforms Airport Lounges into Strategic Engagement Hubs
Through behavioural insight, operational precision, and sensory design, Encalm Hospitality enables partner brands to engage travelers in moments of sustained attention NEW DELHI, April 13, 2026 /PRNewswire/ — Encalm Hospitality is redefining airport lounges as strategic brand environments that move beyond conventional hospitality to measurable loyalty outcomes for partner brands. In a digitally saturated world, the…
-
Precede Biosciences Presents New ASCO 2026 Data Demonstrating Ability of Precede Bio Insight™ to Decode MET-Driven Biology and Resistance in Advanced NSCLC
Data include assessment of MET expression, tumor and immune pathway activity, and lineage plasticity from just 1 mL of plasma in advanced NSCLC Plasma MET test showed high concordance with tissue IHC/FISH in EGFR-mutated NSCLC following progression on first-line targeted therapy (AUC=0.97) Baseline and longitudinal profiling in METex14 skipping NSCLC identified biology associated with therapeutic…
Latest News
About the Author
We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.





